Q1 2025 Earnings Call Transcript May 6, 2025 Krystal Biotech, Inc. misses on earnings expectations. Reported EPS is $1.2 EPS, expectations were $1.38. Operator: Thank you for standing by, and welcome ...

Krystal Biotech, Inc.’s KRYS share price has dipped by 12.19%, which has investors questioning if this is right time to buy.

Despite closing all of its Texas locations years ago, the decades-old Tennessee chain Krystal is slowly bringing its tiny ...

Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today announced that the Company will participate in the BofA Securities 2025 Health Care Conference on May 14, 2025, in Las Vegas. Krish S.

Shares of Krystal Biotech slid after the company's first-quarter earnings missed Wall Street expectations. The stock was down 14% at $139.03, putting shares 11% in the red for the year.

What began as an ordinary offseason for the Kansas City Chiefs in March 2024 was shaken by tragedy with the sudden passing of ...

Krystal Biotech's gene therapy Vyjuvek gains European approval, expanding treatment options for rare skin disease dystrophic ...

PITTSBURGH, May 06, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the "Company”) (NASDAQ: KRYS) today reported financial results for the first quarter ending March 31, 2025 and provided a business ...

Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the ...

Thank you for standing by, and welcome to the Krystal Biotech First Quarter 2025 Earnings Call. At this time, all participants are on a listen-only mode. After the speakers' presentations, there will ...